Efficacy of dapagliflozin in the treatment of HFrEF with obstructive sleep apnea syndrome (DAHOS study): study protocol for a multicentric, prospective, randomized controlled clinical trial

MLA

Liang Xie, et al. “Efficacy of Dapagliflozin in the Treatment of HFrEF with Obstructive Sleep Apnea Syndrome (DAHOS Study): Study Protocol for a Multicentric, Prospective, Randomized Controlled Clinical Trial.” Trials, vol. 24, no. 1, May 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13063-023-07332-x.

APA

Liang Xie, Songsong Song, Shengnan Li, Qin Wei, Hong Liu, Chao Zhao, Fuchao Yu, & Jiayi Tong. (2023). Efficacy of dapagliflozin in the treatment of HFrEF with obstructive sleep apnea syndrome (DAHOS study): study protocol for a multicentric, prospective, randomized controlled clinical trial. Trials, 24(1), 1–8. https://doi.org/10.1186/s13063-023-07332-x

Chicago

Liang Xie, Songsong Song, Shengnan Li, Qin Wei, Hong Liu, Chao Zhao, Fuchao Yu, and Jiayi Tong. 2023. “Efficacy of Dapagliflozin in the Treatment of HFrEF with Obstructive Sleep Apnea Syndrome (DAHOS Study): Study Protocol for a Multicentric, Prospective, Randomized Controlled Clinical Trial.” Trials 24 (1): 1–8. doi:10.1186/s13063-023-07332-x.